Mechanisms of ventricular arrhythmias in the presence of pathological hypertrophy

J Cosín Aguilar1, A Hernandiz Martinez, F Andres Conejos

  • 1Centro Investigacion, Hospital La Fe, Valencia, Spain.

European Heart Journal
|November 1, 1993
PubMed

Insights

Left ventricular hypertrophy (LVH) increases ventricular arrhythmias and sudden death risk. Mechanisms involve electrical changes, collagen, and ischemia, contributing to arrhythmias in LVH patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pathophysiology

Background:

  • Left ventricular hypertrophy (LVH) is associated with an increased incidence of ventricular arrhythmias.
  • LVH is a recognized risk factor for sudden cardiac death.
  • The direct link between malignant arrhythmias in LVH and sudden death remains unclear.

Purpose of the Study:

  • To explore the arrhythmogenic substrate in patients with left ventricular hypertrophy.
  • To identify factors contributing to the increased risk of arrhythmias in LVH.

Main Methods:

  • The study discusses the arrhythmogenic substrate in LVH, focusing on contributing factors and mechanisms.
  • Analysis of electrical changes, collagen matrix growth, and ischemia in hypertrophic myocytes.
  • Examination of reentry mechanisms and after-potential triggers.

Main Results:

  • Ventricular extrasystoles and complex ventricular arrhythmias are more prevalent in LVH.
  • Factors like hypertension, myocyte electrical changes, fibrosis, and ischemia contribute to arrhythmias.
  • The arrhythmogenic substrate involves reentry due to fibrillar stretching/anisotropy and calcium channel-dependent after-potentials.

Conclusions:

  • LVH creates an arrhythmogenic substrate predisposing to ventricular arrhythmias.
  • Multiple factors, including electrical remodeling and ischemia, contribute to arrhythmia generation in LVH.
  • Understanding these mechanisms is crucial for managing sudden death risk in LVH patients.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...